Human acute promyelocytic leukemia cells (NB4)

Human acute promyelocytic leukemia cells (NB4) are invaluable for medical research and drug development enabling scientists to study the underlying mechanisms of leukemia and test potential therapeutic agents in a controlled environment With a specific focus on dry ice preservation and live cell transportation in T25 flasks these cells can be efficiently maintained for various applications without compromising viability ensuring that researchers can conduct high-quality experiments on monocytes in suspended growth under optimal conditions Additionally by maintaining a culture medium of 90% RPMI-1640 and 10% FBS researchers can foster an ideal environment for cellular responses facilitating groundbreaking discoveries in hematology and oncology These applications not only enhance our understanding of leukemia treatment but also pave the way for innovative strategies in cell-based therapies